BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8363768)

  • 1. Low prevalence of positive tuberculin tests in homo-/bisexual white men from Seattle: implications for anergy testing.
    Nolan CM; Dunphy CA; Krueger LE; Goldbaum GM; Wood RW
    AIDS; 1993 Jun; 7(6):895-6. PubMed ID: 8363768
    [No Abstract]   [Full Text] [Related]  

  • 2. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis.
    Almeida Santos J; Duarte R; Nunes C
    Clin Respir J; 2020 Jun; 14(6):541-548. PubMed ID: 32052551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S; Baraia-Etxaburu J; Bouza E; Parras F; Pérez-Tascón M; Miralles P; Vicente T; Alberdi JC; Cosín J; López-Gay D
    Ann Intern Med; 1993 Aug; 119(3):194-8. PubMed ID: 8100693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at risk of tuberculosis.
    Maas JJ; Foudraine NA; Schellekens PT; Mensen ME; Veenstra J; Roos MT; van Leeuwen R; Coutinho RA
    AIDS; 1999 Sep; 13(13):1784-5. PubMed ID: 10509583
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K; Alaei A; Mansouri D
    East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico.
    Velasquez MG; Laniado-Laborin R; Rodwell TC; Cerecer P; Lozada R; Cuevas-Mota J; Burgos JL; Garfein RS
    Rev Panam Salud Publica; 2012 Jul; 32(1):30-5. PubMed ID: 22910722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS in bisexual men in the United States: epidemiology and transmission to women.
    Chu SY; Peterman TA; Doll LS; Buehler JW; Curran JW
    Am J Public Health; 1992 Feb; 82(2):220-4. PubMed ID: 1739151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the risk of tuberculosis among HIV-infected patients.
    Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
    AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis.
    Jordan TJ; Lewit EM; Montgomery RL; Reichman LB
    JAMA; 1991 Jun; 265(22):2987-91. PubMed ID: 2033771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health of lesbian, gay, bisexual, and transgender populations.
    Lancet; 2011 Apr; 377(9773):1211. PubMed ID: 21481690
    [No Abstract]   [Full Text] [Related]  

  • 15. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The negative tuberculin test. Tuberculin, HIV, and anergy panels.
    Pesanti EL
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1699-709. PubMed ID: 7710481
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV transmission: Women's risk from bisexual men.
    Wood RW; Krueger LE; Pearlman TC; Goldbaum G
    Am J Public Health; 1993 Dec; 83(12):1757-9. PubMed ID: 8259812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis.
    MMWR Recomm Rep; 1991 Apr; 40(RR-5):27-32. PubMed ID: 2034206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary confidential HIV testing of STD patients in Switzerland, 1990-5: HIV test refusers cause different biases on HIV prevalences in heterosexuals and homo/bisexuals. Swiss Network of Dermatovenereology Policlinics.
    Paget WJ; Zwahlen M; Eichmann AR
    Genitourin Med; 1997 Dec; 73(6):444-7. PubMed ID: 9582457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis knowledge among New York City injection drug users.
    Wolfe H; Marmor M; Maslansky R; Nichols S; Simberkoff M; Des Jarlais D; Moss A
    Am J Public Health; 1995 Jul; 85(7):985-8. PubMed ID: 7604926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.